31/07/2007 (Agence Europe) - The diabetes simulation has brought to light just how difficult it is to provide clear and accurate information to patients. Following the high number of criticisms (see the results of the consultation online at: http: //ec.europa.eu/health/ph_overview/other_policies/pharmaceutical/consultation_en.htm), the High Level Pharmaceutical Forum recently called on the European Commission and the experts from member states to go back to the drawing board on the...